Investigating the particle engineering of colistin for pulmonary delivery

David Morton; Teresa Jong; Jian Li; John Hale; Roger Nation; Ian Larson

Investigating the particle engineering of colistin for pulmonary delivery

David Morton, Teresa Jong, Jian Li, John Hale, Roger Nation, Ian Larson

Drug Delivery Disposition & Dynamics

Research output: Chapter in Book/Report/Conference proceeding › Conference Paper › Research › peer-review

Abstract

Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.

Original language	English
Title of host publication	Respiratory Drug Delivery Europe 2011
Editors	Richard N Dalby, Peter R Byron, Joanne Peart, Julie D Suman, Paul M Young
Place of Publication	USA
Publisher	Davis Healthcare International Publishing
Pages	367 - 371
Number of pages	5
ISBN (Print)	1933722517
Publication status	Published - 2011
Event	Respiratory Drug Delivery 2011 - Intercontinental Hotel, Berlin, Germany Duration: 3 May 2011 → 6 May 2011

Conference

Conference	Respiratory Drug Delivery 2011
Country/Territory	Germany
City	Berlin
Period	3/05/11 → 6/05/11

1 Conference Paper

Investigating the particle engineering of colistin for pulmonary delivery
Jong, T., Li, J., Hale, J., Morton, D. & Larson, I., 2011, Proceedings of the 1st Electronic Conference on Pharmaceutical Sciences. He, J. (ed.). Basel, Switzerland: MDPI AG, p. 1 - 6 6 p.
Research output: Chapter in Book/Report/Conference proceeding › Conference Paper › Other › peer-review

Cite this

@inproceedings{4e5d1ff1c03a46389b8faf3e730d10cb,

title = "Investigating the particle engineering of colistin for pulmonary delivery",

abstract = "Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.",

author = "David Morton and Teresa Jong and Jian Li and John Hale and Roger Nation and Ian Larson",

year = "2011",

language = "English",

isbn = "1933722517",

pages = "367 -- 371",

editor = "Dalby, {Richard N} and Byron, {Peter R} and Joanne Peart and Suman, {Julie D} and Young, {Paul M}",

booktitle = "Respiratory Drug Delivery Europe 2011",

publisher = "Davis Healthcare International Publishing",

note = "Respiratory Drug Delivery 2011 ; Conference date: 03-05-2011 Through 06-05-2011",

}

Investigating the particle engineering of colistin for pulmonary delivery. / Morton, David; Jong, Teresa; Li, Jian et al.
Respiratory Drug Delivery Europe 2011. ed. / Richard N Dalby; Peter R Byron; Joanne Peart; Julie D Suman; Paul M Young. USA: Davis Healthcare International Publishing, 2011. p. 367 - 371.

Research output: Chapter in Book/Report/Conference proceeding › Conference Paper › Research › peer-review

TY - GEN

T1 - Investigating the particle engineering of colistin for pulmonary delivery

AU - Morton, David

AU - Jong, Teresa

AU - Li, Jian

AU - Hale, John

AU - Nation, Roger

AU - Larson, Ian

PY - 2011

Y1 - 2011

N2 - Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.

AB - Lung infections represent a significant cause of mortaility to specific patient groups, notably custic fibrosis patients. While antibiotics have been effective against infection - causing pathogenuic bacteria such as Pseudomonas aeruginosa, the onset of antibiotic resistance has been a major concern and meant that alternative antibiotics and/or delivery mechanisms are required to achieve effective treatment.

M3 - Conference Paper

SN - 1933722517

SP - 367

EP - 371

BT - Respiratory Drug Delivery Europe 2011

A2 - Dalby, Richard N

A2 - Byron, Peter R

A2 - Peart, Joanne

A2 - Suman, Julie D

A2 - Young, Paul M

PB - Davis Healthcare International Publishing

CY - USA

T2 - Respiratory Drug Delivery 2011

Y2 - 3 May 2011 through 6 May 2011

ER -